Erba Diagnostics (ERB) Misses Q1 EPS by 1c

Erba Diagnostics (NYSE: ERB) reported Q1 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $6.37 million versus the consensus estimate of $7.67 million.

For earnings history and earnings-related data on Erba Diagnostics (ERB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'